Press Releases Amniotics AB

Equities

AMNI

SE0015961016

Market Closed - Nasdaq Stockholm Other stock markets 04:21:22 08/05/2024 pm IST			5-day change	1st Jan Change
0.0037 ^SEK	+2.78%		-5.13%	-58.89%

22/03	Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.	CI
22/02	Amniotics AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MAGLE GROUP REPORTS OUTCOME AND EXTENDS THE ACCEPTANCE PERIOD FOR THE PUBLIC TENDER OFFER TO THE SHAREHOLDERS OF AMNIOTICS	07/05	AQ
Magle Chemoswed Q1 - Expansion by acquisition	19/04	AQ
Magle Chemoswed Holding AB publishes offer document and announces updated timetable regarding the cash offer to the shareholders of Amniotics AB	05/04	AQ
Magle Chemoswed Holding AB (publ) withdraws dividend proposal and enters into term loan facilities amounting to SEK 12 million in total	22/03	AQ
Statement from the Board of Directors of Amniotics regarding the public offer from Magle Chemoswed	22/03	AQ
Magle Chemoswed Holding AB announces a recommended cash offer of SEK 0.004 per share to the shareholders of Amniotics AB	22/03	AQ
Amniotics secures short-term capital needs by extending loan agreement and entering into a service agreement	21/03	AQ
Amniotics announces the outcome of the exercise of warrants series TO 3	11/03	AQ
The exercise period for warrants series TO 3 in Amniotics begins today	26/02	AQ
Amniotics Q4 2023 - Investigator-sponsored trial in lung transplantation needs funding	26/02	AQ
Amniotics AB (publ) Report for the fourth quarter 2023.	22/02	AQ
Information about the Annual General Meeting and appointed Nomination Committee of Amniotics	21/12	AQ
Amniotics receives orphan designation for PulmoStem® from the European Commission for the Treatment of Primary Graft Dysfunction following Lung Transplantation	14/12	AQ
Amniotics Q3 2023 - Rights Issue Foundation for Lung Transplantation Study	28/11	AQ
Amniotics AB (publ) Report for the third Quarter 2023	27/11	AQ
Renewed GMP certification	23/11	AQ
Amniotics receives positive opinion on orphan designation for PulmoStem® from the European Medicines Agency for the Treatment of Primary Graft Dysfunction following Lung Transplantation	20/11	AQ
Last day of trading in paid subscribed units in Amniotics	17/11	AQ
Amniotics announces outcome in rights issue	27/23/27	AQ
The subscription period in Amniotics’ rights issue commences today	11/23/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Amniotics AB

Equities

AMNI

SE0015961016

Press Releases

Filters